Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury.
Cardinal H, Dieudé M, Brassard N, Qi S, Patey N, Soulez M, Beillevaire D, Echeverry F, Daniel C, Durocher Y, Madore F, Hébert MJ.
Cardinal H, et al. Among authors: daniel c.
Am J Transplant. 2013 Apr;13(4):861-874. doi: 10.1111/ajt.12168. Epub 2013 Feb 22.
Am J Transplant. 2013.
PMID: 23432943
Free article.